Brain site-specific gene expression analysis in Alzheimer's disease patients

European Journal of Clinical Investigation

Volumn 36, Issue 11, 2006, Pages 820-830

  Yokota, T ^b,c   Mishra, M ^a   Akatsu, H ^d,e   Tani, Y ^d,e   Miyauchi, T ^c   Yamamoto, T ^d,e   Kosaka, K ^d,e   Nagai, Y ^b   Sawada, T ^b   Heese, K ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b BF Research Institute   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Fukushimura Hospital   (Japan)

^e NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; MAP1B; Microtubules; Neurodegeneration; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHAPERONE; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; HEAT SHOCK PROTEIN 90; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; PROTEASOME; RETICULON 3; SMALL INTERFERING RNA; TRIPARTITE MOTIF CONTAINING PROTEIN 32; TRIPARTITE MOTIF CONTAINING PROTEIN 37; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CELL ORGANELLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOSKELETON; DEGENERATIVE DISEASE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROTUBULE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TRANSPORT; SENILE PLAQUE; SUBTRACTIVE HYBRIDIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; FEMALE; GENE LIBRARY; HEAT-SHOCK PROTEINS; HUMANS; MALE; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; OCCIPITAL LOBE; PLAQUE, AMYLOID; RNA, MESSENGER; SENILE PLAQUES; TEMPORAL LOBE; TRANSCRIPTION FACTORS;

EID: 33749998298     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01722.x     Document Type: Article

References (42)

1. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003;43:545-84.
2. Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004;6:1054-61.
3. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005, 1739: 198-210.
4. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 2001;284:310-16.
5. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 2002;70:462-73.
6. Cao W, Epstein C, Liu H, DeLoughery C, Ge N, Lin J et al. Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study. BMC Genomics 2004;5:26.
7. Heese K, Nagai Y, Sawada T. Identification of a new synaptic vesicle protein 2B mRNA transcript which is up-regulated in neurons by amyloid beta peptide fragment (1-42). Biochem Biophys Res Commun 2001;289:924-8.
8. Shi J, Cai W, Chen X, Ying K, Zhang K, Xie Y. Identification of dopamine responsive mRNAs in glial cells by suppression subtractive hybridization. Brain Res 2001;910:29-37.
9. Kakinuma Y, Saito F, Osawa S, Miura M. A mechanism of impaired mobility of oligodendrocyte progenitor cells by tenascin C through modification of wnt signaling. FEBS Lett 2004;568:60-4.
10. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996;93:6025-30.
11. Diatchenko L, Lukyanov S, Lau YF, Siebert PD. Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Meth Enzymol 1999;303:349-80.
12. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
13. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59.
14. Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T et al. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 2002;196:63-9.
15. Akatsu H, Yamagata H, Chen Y, Miki T, Kamino K, Takeda M et al. TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction. Br J Haematol 2004;127:440-7.
16. Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol (Berl) 1996;92:197-201.
17. Pruitt KD, Maglott DR. RefSeq and LocusLink: NCBI gene-centered resources. Nucl Acids Res 2001;29:137-40.
18. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
19. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-3.
20. Heese K, Yamada T, Nagai Y, Sawada T. CGI-94 controls neuronal survival. Brain Aging 2002;2:44-8.
21. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-5.
22. Maxwell MM, Pasinelli P, Kazantsev AG, Brown RH Jr. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci USA 2004;101:3178-83.
23. Heese K, Fujita M, Akatsu H, Yamamoto T, Kosaka K, Nagai Y et al. The splicing regulatory protein p18SRP is down-regulated in Alzheimer's disease brain. J Mol Neurosci 2004;24:269-76.
24. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V et al. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000;75:991-1003.
25. Tucker RP. The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res Brain Res Rev 1990;15:101-20.
26. Duyckaerts C. Looking for the link between plaques and tangles. Neurobiol Aging 2004;25:735-9.
27. Kins S, Crameri A, Evans DR, Hemmings BA, Nitsch RM, Gotz J. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J Biol Chem 2001;276:38193-200.
28. Kondratick CM, Vandre DD. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. J Neurochem 1996;67:2405-16.
29. Goold RG, Gordon-Weeks PR. Microtubule-associated protein 1B phosphorylation by glycogen synthase kinase 3beta is induced during PC12 cell differentiation. J Cell Sci 2001;114:4273-84.
30. Takei Y, Teng J, Harada A, Hirokawa N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol 2000;150:989-1000.
31. Teng J, Takei Y, Harada A, Nakata T, Chen J, Hirokawa N. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J Cell Biol 2001;155:65-76.
32. Gonzalez-Billault C, Engelke M, Jimenez-Mateos EM, Wandosell F, Caceres A, Avila J. Participation of structural microtubule-associated proteins (MAPs) in the development of neuronal polarity. J Neurosci Res 2002;67:713-19.
33. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci USA 2001;98:6336-41.
34. Song S, Kim SY, Hong YM, Jo DG, Lee JY, Shim SM et al. Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity. Mol Cell 2003;12:553-63.
35. von Rotz RC, Kins S, Hipfel R, von der Kammer H, Nitsch RM. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease. Eur J Neurosci 2005;21:1289-98.
36. Shimura H, Schwartz D, Gygi SP, Kosik KS. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 2004;279:4869-76.
37. Horn EJ, Albor A, Liu Y, El-Hizawi S, Vanderbeek GE, Babcock M et al. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 2004;25:157-67.
38. Kallijarvi J, Lahtinen U, Hamalainen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki AE. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res 2005;308:146-55.
39. Song S, Jung YK. Alzheimer's disease meets the ubiquitin-proteasome system. Trends Mol Med 2004;10:565-70.
40. He W, Lu Y, Qahwash I, Hu XY, Chang A, Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med 2004;10:959-65.
41. Wildasin K. Role of reticulon proteins in Alzheimer's disease. Lancet Neurol 2004;3:576.
42. Yan R, Shi Q, Hu X, Zhou X. Reticulon proteins: emerging players in neurodegenerative diseases. Cell Mol Life Sci 2006;63:877-89.